Is It Time To Consider OncoMed Pharmaceuticals Again?

Given OncoMed's strong cash position and its partnerships, the company looks best positioned in the cancer stem cell therapy space. Every year an estimated 12 million people are diagnosed with cancer globally.

http://ift.tt/1r2GGMH